Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Channel One Style.
Press releases published on April 28, 2025
TikTok’s Favorite Foodie Kate Norkeliunas Teams Up with MGA’s Miniverse™ to Launch Make It Mini From Scratch™, The Collectible You Make Yourself
GlobeNewswire
·
April 28, 2025
LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The original miniature brand where DIY meets collectability, MGA’s Miniverse™, is proud to debut its newest collection, MGA’s Miniverse™ Make It Mini From Scratch™. With more than 4 billion views of # …
Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu
GlobeNewswire
·
April 28, 2025
CHENGDU, China, April 28, 2025 (GLOBE NEWSWIRE) -- On April 29, on the eve of International Workers' Day, the countdown to the TWG 2025 Chengdu will reach the critical 100-day mark. Chengdu, the host city, is welcoming the upcoming The World Games 2025 …
Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025
GlobeNewswire
·
April 28, 2025
PETAH TIKVA, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced management’s participation in the 20th Annual …
Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity Progression free survival (PFS) data to date represents a near doubling of the benchmarking …
EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
GlobeNewswire
·
April 28, 2025
Initial real-world data from nearly 40,000 EYLEA HD patients will provide early insights on effectiveness of EYLEA HD in everyday clinical practice New indirect comparisons will evaluate EYLEA HD and faricimab on measures of efficacy, dosing frequency and …
Kandi Technologies Reports 2024 Financial Results
GlobeNewswire
·
April 28, 2025
Revenue Of $127.6M up 3.2% YoY, Supported by Expanded Product Reach And Improved Geographic Balance Electric Off-Road Vehicle Revenue Rose 8.9% YoY, Reinforcing Core Segment Leadership Enhanced Supply Chain Flexibility with Taiwan Upgrades, While …
Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
LONDON and PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced …
Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its first quarter 2025 financial …
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
GlobeNewswire
·
April 28, 2025
WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today …
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
GlobeNewswire
·
April 28, 2025
NEW HAVEN, Conn., April 28, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will review first …
Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
GlobeNewswire
·
April 28, 2025
EXTON, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- This spring, Lungpacer Medical clinical experts and device innovators will be featured presenters at top industry events. Speakers will demonstrate how novel interventional therapies can free critically ill …
Clear Blue Technologies International to provide Corporate Update and Report Fiscal 2024 Financial Results and Host Conference Call on Thursday, May 1st, 2025
GlobeNewswire
·
April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (TSXV: CBLU) the Smart Off-Grid™ Company, today announces that it will provide a corporate update and also report financial results for its fiscal 2024 on Wednesday, …
Village Farms International Takes Top Honors at the 2025 Stevie® Awards
GlobeNewswire
·
April 28, 2025
VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) was named the winner of two Gold Stevie® Awards and one Bronze Stevie® Award in the 23rd Annual American …
Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate …
Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax
GlobeNewswire
·
April 28, 2025
ROCKVILLE, Md. and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
GlobeNewswire
·
April 28, 2025
BEDFORD, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it plans to issue a press release regarding first quarter …
Nayax to Showcase End-to-End Payment Ecosystem at The NAMA Show, May 7-9 in Las Vegas
GlobeNewswire
·
April 28, 2025
HERZLIYA, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement payments and loyalty platform designed to help merchants scale their business, will be showcasing its range of solutions at The NAMA …
International Petroleum Corporation to release Q1 2025 Financial and Operational Results on May 6, 2025
GlobeNewswire
·
April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC) (TSX, Nasdaq Stockholm: IPCO) will publish its financial and operating results and related management’s discussion and analysis for the three months ending 31 March 2025, …
Dubai’s Web 3.0 Momentum Accelerates as Global Stakeholders Gather for Unchained Summit
GlobeNewswire
·
April 28, 2025
DUBAI, United Arab Emirates, April 28, 2025 (GLOBE NEWSWIRE) -- In the middle of the Gulf, something very deep is unfolding. Web 3.0 & Blockchain is no longer a buzzword; it’s a building block. And in Dubai, the future of Web 3.0 isn’t just coming; it’s …
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
GlobeNewswire
·
April 28, 2025
Event titled “BV100 Shows Survival Benefit in Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter. What Does that Mean for Patients? A Perspective from the US and from Asia” Featuring Professor David Paterson and …